Untitled Category

CDMO Expansions: • SEQENS has entered into exclusive negotiations with Novartis for the potential acquisition of the French company Cellforcure and its cell & gene therapy development and production site. CELLforCURE’s has large-scale industrial production of cell & gene therapies. With over 10,000

CDMO Expansions: • SEQENS has entered into exclusive negotiations with Novartis for the potential acquisition of the French company Cellforcure and its cell & gene therapy development and production site. CELLforCURE’s has large-scale industrial production of cell & gene therapies. With over 10,000

Facility and Expansions • MilliporeSigma Invests $25M to Expand Cell Culture Media Production in Kansas by 98,000sf. Cell culture media is an essential raw material used in the manufacture of therapies and in processes for vaccines, gene therapy, and mAb manufacturing. (genengnews) • Lonza and Vert